Molina Healthcare, Inc. (NYSE:MOH) Shares Sold by Handelsinvest Investeringsforvaltning

Handelsinvest Investeringsforvaltning lessened its holdings in Molina Healthcare, Inc. (NYSE:MOH) by 34.2% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,237 shares of the company’s stock after selling 642 shares during the quarter. Handelsinvest Investeringsforvaltning’s holdings in Molina Healthcare were worth $508,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of MOH. Norges Bank acquired a new position in shares of Molina Healthcare in the 4th quarter valued at about $275,143,000. Wellington Management Group LLP boosted its position in Molina Healthcare by 12.8% in the 4th quarter. Wellington Management Group LLP now owns 3,831,100 shares of the company’s stock worth $1,384,215,000 after purchasing an additional 436,060 shares in the last quarter. Capital Research Global Investors grew its stake in shares of Molina Healthcare by 5.4% during the 4th quarter. Capital Research Global Investors now owns 2,430,283 shares of the company’s stock worth $878,086,000 after purchasing an additional 123,894 shares during the period. The Manufacturers Life Insurance Company increased its holdings in shares of Molina Healthcare by 127.0% during the 4th quarter. The Manufacturers Life Insurance Company now owns 192,847 shares of the company’s stock valued at $69,678,000 after purchasing an additional 107,895 shares in the last quarter. Finally, Assenagon Asset Management S.A. lifted its stake in shares of Molina Healthcare by 4,019.2% in the 4th quarter. Assenagon Asset Management S.A. now owns 103,185 shares of the company’s stock valued at $37,282,000 after purchasing an additional 100,680 shares during the period. 98.50% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Molina Healthcare

In other Molina Healthcare news, Director Ronna Romney sold 250 shares of Molina Healthcare stock in a transaction dated Tuesday, May 21st. The shares were sold at an average price of $343.27, for a total transaction of $85,817.50. Following the transaction, the director now directly owns 16,945 shares of the company’s stock, valued at $5,816,710.15. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, COO James Woys sold 10,000 shares of the stock in a transaction on Wednesday, May 22nd. The stock was sold at an average price of $345.15, for a total transaction of $3,451,500.00. Following the completion of the transaction, the chief operating officer now directly owns 53,613 shares in the company, valued at approximately $18,504,526.95. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Ronna Romney sold 250 shares of the business’s stock in a transaction dated Tuesday, May 21st. The shares were sold at an average price of $343.27, for a total transaction of $85,817.50. Following the completion of the sale, the director now owns 16,945 shares in the company, valued at $5,816,710.15. The disclosure for this sale can be found here. 1.11% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. Bank of America cut shares of Molina Healthcare from a “neutral” rating to an “underperform” rating and set a $439.00 price objective for the company. in a report on Thursday, March 28th. JPMorgan Chase & Co. cut their price target on Molina Healthcare from $435.00 to $420.00 and set an “overweight” rating for the company in a research note on Thursday, May 30th. Barclays lowered their price target on Molina Healthcare from $437.00 to $430.00 and set an “equal weight” rating on the stock in a research report on Thursday, April 25th. TD Cowen cut their price objective on Molina Healthcare from $453.00 to $412.00 and set a “buy” rating for the company in a research report on Tuesday, April 30th. Finally, Robert W. Baird started coverage on Molina Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $405.00 target price on the stock. One analyst has rated the stock with a sell rating, four have given a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $407.45.

Molina Healthcare Stock Performance

NYSE:MOH opened at $292.31 on Wednesday. Molina Healthcare, Inc. has a twelve month low of $288.79 and a twelve month high of $423.92. The company has a market cap of $17.13 billion, a P/E ratio of 15.84, a P/E/G ratio of 0.91 and a beta of 0.58. The company has a current ratio of 1.49, a quick ratio of 1.49 and a debt-to-equity ratio of 0.53. The company’s 50-day moving average price is $325.40 and its 200-day moving average price is $361.87.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, April 24th. The company reported $5.73 earnings per share for the quarter, topping analysts’ consensus estimates of $5.46 by $0.27. Molina Healthcare had a net margin of 2.99% and a return on equity of 29.86%. The business had revenue of $9.93 billion for the quarter, compared to analyst estimates of $9.45 billion. During the same period last year, the company posted $5.81 EPS. The business’s revenue was up 21.9% on a year-over-year basis. On average, sell-side analysts forecast that Molina Healthcare, Inc. will post 23.56 earnings per share for the current fiscal year.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.